Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case report of melanotic neuroectodermal tumor of infancy complicated with congenital heart disease and hypothyroidism. | Front Cardiovasc Med | 2022 | 36440003 | PubTator, text mining | PubMed |
| Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis. | Front Immunol | 2022 | 36439173 | PubTator, text mining | PubMed |
| ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer. | Front Genet | 2022 | 36437939 | PubTator, text mining | PubMed |
| CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. | Redox Biol | 2022 | 36427397 | PubTator, text mining | PubMed |
| Widespread hypertranscription in aggressive human cancers. | Sci Adv | 2022 | 36417526 | PubTator, text mining | PubMed |
| Alveolar cell fate selection and lifelong maintenance of AT2 cells by FGF signaling. | Nat Commun | 2022 | 36414616 | PubTator, text mining | PubMed |
| Extrarenal Wilms' Tumour of the Ovary: A case report. | Sultan Qaboos Univ Med J | 2022 | 36407712 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. | Front Endocrinol (Lausanne) | 2022 | 36407322 | PubTator, text mining | PubMed |
| Ewing sarcoma: what trends in recent works? A holistic analysis with global productivity: A cross-sectional study. | Medicine (Baltimore) | 2022 | 36401481 | PubTator, text mining | PubMed |
| Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer. | Cell Rep Med | 2022 | 36384095 | PubTator, text mining | PubMed |
| The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression. | Elife | 2022 | 36383412 | PubTator, text mining | PubMed |
| HSP90 facilitates stemness and enhances glycolysis in glioma cells. | BMC Neurol | 2022 | 36368999 | PubTator, text mining | PubMed |
| Recent Updates on the Functional Impact of Kahweol and Cafestol on Cancer. | Molecules | 2022 | 36364160 | PubTator, text mining | PubMed |
| Simulated Microgravity Modulates Focal Adhesion Gene Expression in Human Neural Stem Progenitor Cells. | Life (Basel) | 2022 | 36362982 | PubTator, text mining | PubMed |
| Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer. | Int J Mol Sci | 2022 | 36362153 | PubTator, text mining | PubMed |
| Generation of Lens Progenitor Cells and Lentoid Bodies from Pluripotent Stem Cells: Novel Tools for Human Lens Development and Ocular Disease Etiology. | Cells | 2022 | 36359912 | PubTator, text mining | PubMed |
| Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification. | Biomolecules | 2022 | 36358994 | PubTator, text mining | PubMed |
| CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers. | Cancers (Basel) | 2022 | 36358827 | PubTator, text mining | PubMed |
| TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma. | Science | 2022 | 36356143 | PubTator, text mining | PubMed |
| MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation. | Biomark Insights | 2022 | 36341281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=22